1
Characterization of the Profile of Dysarthria in Huntington’s Disease, Using the Clinical Evaluation Battery of Dysarthria
Condition(s):Dysarthria; Huntington DiseaseLast Updated:May 5, 2017Withdrawn
Chorea, Huntington: 209 Clinical Trials, Page 1 of 21
Hide Studies Not Open or Pending
2
Couple and Spouse Caregiver in Huntington’s Disease
Condition(s):Huntington DiseaseLast Updated:May 19, 2020Recruiting
3
Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington Disease
Condition(s):Chorea, HuntingtonLast Updated:May 20, 2020Recruiting
4
Study of Huntington Patients in Connection With European Huntington’s Disease Network (EHDN)
Condition(s):Huntington DiseaseLast Updated:March 19, 2012Unknown status
5
Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease
Condition(s):Chorea, HuntingtonLast Updated:May 22, 2020Enrolling by invitation
6
Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington’s Disease
Condition(s):Huntington’s DiseaseLast Updated:November 17, 2017Completed
7
Deep Brain Stimulation Treatment for Chorea in Huntington’s Disease
Condition(s):Huntington Disease; Deep Brain StimulationLast Updated:January 28, 2020Not yet recruiting
8
A Study of the Novel Drug Dimebon in Patients With Huntington’s Disease
Condition(s):Huntington’s DiseaseLast Updated:June 8, 2015Completed
9
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington’s Disease
Condition(s):Huntington’s DiseaseLast Updated:March 7, 2019Completed
10
Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
Condition(s):Huntington DiseaseLast Updated:March 6, 2019Completed